Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veerman

Showing results (931-940 of 941) with videos related to

Pageof 95
Sort By:
Nature Cell Biology|September 5, 2018
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancerKristiaan J Lenos, Daniël M Miedema, Sophie C Lodestijn, et al.
Journal of Medicinal Chemistry|April 20, 2018
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal ActivityAntoni R Blaazer, Abhimanyu K Singh, Erik de Heuvel, et al.
Annals of the New York Academy of Sciences|February 2, 2023
Advancing understanding of land-atmosphere interactions by breaking discipline and scale barriersJordi Vilà-Guerau de Arellano, Oscar Hartogensis, Imme Benedict, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 9, 2025
The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task ForceHélène Verdoux, Robert A Bittner, Alkomiet Hasan, et al.
Trials|February 9, 2020
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trialMarieke J H Begemann, Ilse A Thompson, Wim Veling, et al.
Psychological Medicine|October 19, 2021
Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysisPriscilla P Oomen, Marieke J H Begemann, Bodyl A Brand, et al.
The Journal of Infectious Diseases|February 1, 2021
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19Nico A F Janssen, Inge Grondman, Aline H de Nooijer, et al.
Translational Psychiatry|April 8, 2022
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disordersC Okhuijsen-Pfeifer, M Z van der Horst, C A Bousman, et al.
Lancet (London, England)|June 2, 2014
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013Marie Ng, Tom Fleming, Margaret Robinson, et al.
Lancet (London, England)|December 19, 2012
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Stephen S Lim, Theo Vos, Abraham D Flaxman, et al.
Pageof 95

Showing results (931-940 of 941) with videos related to

Sort By:
Pageof 95
Nature Cell Biology|September 5, 2018
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancerKristiaan J Lenos, Daniël M Miedema, Sophie C Lodestijn, et al.
Journal of Medicinal Chemistry|April 20, 2018
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal ActivityAntoni R Blaazer, Abhimanyu K Singh, Erik de Heuvel, et al.
Annals of the New York Academy of Sciences|February 2, 2023
Advancing understanding of land-atmosphere interactions by breaking discipline and scale barriersJordi Vilà-Guerau de Arellano, Oscar Hartogensis, Imme Benedict, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 9, 2025
The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task ForceHélène Verdoux, Robert A Bittner, Alkomiet Hasan, et al.
Trials|February 9, 2020
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trialMarieke J H Begemann, Ilse A Thompson, Wim Veling, et al.
Psychological Medicine|October 19, 2021
Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysisPriscilla P Oomen, Marieke J H Begemann, Bodyl A Brand, et al.
The Journal of Infectious Diseases|February 1, 2021
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19Nico A F Janssen, Inge Grondman, Aline H de Nooijer, et al.
Translational Psychiatry|April 8, 2022
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disordersC Okhuijsen-Pfeifer, M Z van der Horst, C A Bousman, et al.
Lancet (London, England)|June 2, 2014
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013Marie Ng, Tom Fleming, Margaret Robinson, et al.
Lancet (London, England)|December 19, 2012
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Stephen S Lim, Theo Vos, Abraham D Flaxman, et al.
Pageof 95